Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950649 · ClinicalTrials.gov registry record
Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care
A clinical trial, sponsored by Loma Linda University.
- Terminated
- Registry status
- 189
- Enrollment target
NCT02950649: Clinical Trial study, sponsored by Loma Linda University.
NCT02950649 is a clinical trial that was terminated before completion, run by Loma Linda University. The registered enrollment target is 189 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950649 was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- 189 participants
- Enrollment target
Study Summary
This project is designed to assess the impact of pre-operative use of non-invasive hemodynamic monitoring technologies on improving peri-operative and post-operative care of moderate to high-risk surgical patients with poor functional status by improving the detection of reduced cardiovascular function.
Primary Outcome
Comparison of cardiac index derived from subjective preoeprative assessment to cardiac index derived from device assessment
Interventions
- DEVICE invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences
- DEVICE No Hemodynamic Monitored Guided Assesment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2016-11-17 |
| Est. Completion | 2021-06-14 |
Why NCT02950649 stopped before completion
NCT02950649 is an observational study that tracks outcomes without assigning an intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences is the first listed.
NCT02950649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02950649 about?
NCT02950649 is a clinical study titled "Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care". This project is designed to assess the impact of pre-operative use of non-invasive hemodynamic monitoring technologies on improving peri-operative and post-operative care of moderate to high-risk surgical patients with poor functional status by improving the detection of reduced cardiovascular funct...
What is the current status of trial NCT02950649?
This trial is currently terminated. The enrollment target is 189 participants. The study started on 2016-11-17. Estimated completion is 2021-06-14.
What interventions are being tested in trial NCT02950649?
The interventions under investigation include: invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences (DEVICE), No Hemodynamic Monitored Guided Assesment (DEVICE).
Who is sponsoring clinical trial NCT02950649?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI